
Alvine Pharmaceuticals: Biotech firm innovating therapeutics for autoimmune & inflammatory diseases.
Alvine Pharmaceuticals is a biotechnology company dedicated to developing therapeutics for autoimmune and inflammatory diseases. Founded with the mission to innovate and provide effective treatments for these chronic conditions, Alvine focuses on leveraging cutting-edge scientific research to create novel therapies. Their product pipeline includes various drug candidates aimed at improving the quality of life for patients suffering from autoimmune disorders.
Notable figures affiliated with Alvine Pharmaceuticals include experienced scientists and industry leaders who bring a wealth of knowledge to the company. The firm has attracted significant investment from prominent venture capitalists, underscoring the potential impact of its innovative treatments. Alvine's key achievements include advancing several drug candidates through critical stages of clinical trials, positioning the company as a promising player in the biotech industry.
Aliva Biopharmaceuticals

Avalyn Pharma
avalynpharma.com

Alavita Pharmaceuticals
alavita.lu

Alphina Therapeutics

Alcinous Pharmaceuticals

Equillium
equilliumbio.com

Alivio Therapeutics

Alveolus Bio
alveolusbio.com

Aristea Therapeutics

Osprey Pharmaceuticals USA
ospreypharma.com

Riparian Pharmaceuticals

PIN Pharma
pinpharma.com

Therini Bio
therinibio.com

Vyne Therapeutics

Alkeus Pharmaceuticals
alkeus.com
Companies similar to Alvine Pharmaceuticals include Aliva Biopharmaceuticals, Avalyn Pharma, Alavita Pharmaceuticals and Alphina Therapeutics.
Alvine Pharmaceuticals was founded in 2005.
Alvine Pharmaceuticals' headquarters is located in San Carlos, CA, US.
Alvine Pharmaceuticals' most recent funding round was for $6M (USD) in January 2013.
As of Jan 3, 2013, Alvine Pharmaceuticals has raised a total of $68M (USD).